UK Grants Additional Funds To Vaccines Manufacturing Centre
BioSpectrum Asia|April 2021
The Vaccines Manufacturing and Innovation Centre (VMIC) has been granted an additional £47.6 million by the UK government to support the expansion and acceleration of the programme.

Continue reading your story on the app

Continue reading your story in the magazine

MORE STORIES FROM BIOSPECTRUM ASIAView All

Singapore allows use of Pfizer-BioNTech COVID-19 vaccine in adolescents

The Health Sciences Authority (HSA) at Singapore has extended the authorisation of PfizerBioNTech COVID-19 vaccine for use in adolescents of ages 12 to 15 years for the prevention of COVID-19.

1 min read
BioSpectrum Asia
BioSpectrum Asia June 2021

Shineco to pick 51% stake in Taiwan's Mayah Biological

Shineco, Inc, a producer and distributor of Chinese herbal medicines, organic agricultural and hemp products, has announced that the company and Mayah Biological Holdings, a British Virgin Islands Company headquartered in Taiwan Biomedical Park, has signed a Proposal for Purchase of Equity Interest of Mayah Biological Holding Limited, with respect to the potential purchase of at least 51 per cent equity interests in Mayah Biological by Shineco.

1 min read
BioSpectrum Asia
BioSpectrum Asia June 2021

Heated startup race is on to capture AI-driven APAC healthcare

The Artificial Intelligence (AI) ecosystem in healthcare has grown in the recent past, as companies are looking to capitalise on the benefits provided by AI to improve patient outcomes and enable convenient, cost-effective access to healthcare solutions. In addition to the significant increase in digital penetration and internet connectivity, favourable government policies (e.g., China, Thailand and the Philippines) have been key driving factors of growth in health-tech startups across the Asia Pacific (APAC) region. AI in the APAC healthcare market is set to grow substantially due to increasing investments by Venture Capitalists in AI healthcare startups, cross-industry partnerships and collaborations.

5 mins read
BioSpectrum Asia
BioSpectrum Asia June 2021

US approves Pfizer-BioNTech COVID-19 vaccine for adolescents

The U.S. Food and Drug Administration (FDA) has expanded the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine for the prevention of COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to include adolescents 12 through 15 years of age.

1 min read
BioSpectrum Asia
BioSpectrum Asia June 2021

Singapore advances stem cell tech to first-in-man clinical trial

Institutes and centres under the SingHealth Duke-NUS Academic Medical Centre (AMC) are joining hands together with Singapore’s first private cord blood bank, Cordlife Group Limited (Cordlife), to test a novel technology that expands the number of blood-forming stem cells from stored umbilical cord blood (UCB) in a first-in-man study in Singapore.

1 min read
BioSpectrum Asia
BioSpectrum Asia June 2021

How leveraging intelligent data architecture fast tracks new drug launches

Clinical trials in medical and pharmaceutical research must deal with extreme amounts of diverse data which are generated across several institutions. A flexible data architecture can help shorten time to market.

5 mins read
BioSpectrum Asia
BioSpectrum Asia June 2021

AUSTRALIAN AGED CARE GETS BOOSTER DOSE

In 2017, there were 3.8 million Australians aged 65 and over (comprising 15 per cent of the total population) —increasing from 319,000 (5 per cent) in 1927 and 1.3 million (9 per cent) in 1977. The number and proportion of older Australians is expected to continue to grow. By 2057, it is projected that there will be 8.8 million older people in Australia (22 per cent of the population); by 2097, 12.8 million people (25 per cent) will be aged 65 and over according to Australian Bureau of Statistics (ABS) 2017. Looking at the growing trend, the government of Australia has a separate ministry for Senior Australians and Aged Care Services and undertaken many steps to support them with respect, care and dignity.

10+ mins read
BioSpectrum Asia
BioSpectrum Asia June 2021

Expert panel to advise WHO on spread of zoonotic diseases

International organisations have come together to launch a new One Health High-Level Expert Panel to improve understanding of how diseases with the potential to trigger pandemics, emerge and spread.

1 min read
BioSpectrum Asia
BioSpectrum Asia June 2021

Africa CDC Takes New Steps To Fight Covid-19

African Ministers of Health have committed to support the Africa Centres for Disease Control and Prevention’s (Africa CDC), new initiatives to double down on the ongoing continental recovery from the COVID-19 pandemic.

1 min read
BioSpectrum Asia
BioSpectrum Asia June 2021

Is 2.16B Jabs Target Unachievable For India?

India currently is suffering from an acute shortage of vaccines, due to which various vaccination centres have had to shut down vaccinations for several days. To ease access to vaccines, the Government of India has permitted states to source COVID-19 vaccines from manufacturers across the globe.

5 mins read
BioSpectrum Asia
BioSpectrum Asia June 2021